EULAR 2025 Congress
June 11 - 14, 2025 | Barcelona, Spain
We are excited to join the European Congress of Rheumatology (EULAR 2025), the primary platform for exchanging groundbreaking research projects, best practices, and the latest advancements in rheumatology. We will attend alongside our partner FORWARD, the National Databank for Rheumatic Diseases and largest patient-reported research databank for rheumatic disorders in the United States.
Together, in 2023 we launched the lupus registry that allows researchers to access the real-life health experience of lupus patients to advance research, improve patient outcomes, and make better clinical decisions.
Meet our delegates on-site and discover how to accelerate solutions for people with lupus with our comprehensive approach, exclusive data access, and our valuable in-house lupus expertise.
Our Research at EULAR 2025 Congress
Mortality Rates and Causes of Death Among Patients With Systemic Lupus Erythematosus
Saturday, June 14, 2025 | 10:15 am CEST
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by multi-organ involvement. Its prevalence is disproportionately higher in women and individuals of Black ethnicity. Research indicates that SLE patients experience higher rates of comorbidities and mortality compared to the general population. Despite improvements in survival rates, significant disparities persist. This study aims to (i) describe the mortality rates and primary causes of death among individuals with SLE and (ii) to evaluate the prognostic factors influencing mortality.
Authors: Cortinez Rojas, Valentina; Pedro, Sofia; Katz, Patti; Michaud, Kaleb; Aigner, Annette; Park, Minjee
Meet Our Delegates
Minjee Park
Partner, Real-World Evidence
Jennifer Lannon
Senior Director, Registries and Partnerships, Patient-Centered Outcomes Research
Understand the Lives of People With Lupus and Launch a Product That Truly Fits Their Needs
At Alira Health, we have developed specialized expertise in lupus, aiding companies in addressing unmet lupus patient needs. Our aim is to drive innovation in this challenging area, especially in underserved segments and communities.
Subscribe to our newsletter for the latest news, events, and thought leadership